Skip to main content
. 2020 May 16;43(8):745–749. doi: 10.1007/s40264-020-00932-5
It is important that adverse drug reaction insights are communicated to patients, with the aim to reduce harm.
Collaboration between a pharmacovigilance centre and a patient organization to communicate adverse drug reaction insights to patients is feasible.
Social media communication generates more engagement than other communication channels.